Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
128.7 USD | +0.85% | -0.91% | +17.45% |
May. 02 | Merck: encouraging results in gastric cancer | CF |
May. 01 | Merck Says Keytruda Meets Primary Endpoint in Late-Stage Gastric Cancer Trial | MT |
Official Publications
Slide show Q1 | CO | |
1st quarter results | CO | |
SEC Filing 8K | CO | |
Proxy Statments | CO | |
Acquisition | CO | |
SEC Filing 10K | CO | |
SEC Filing 8K | CO | |
Slide show results | CO | |
Annual results | CO | |
SEC Filing 8K | CO | |
Dividends | CO | |
Dividends | CO | |
SEC Filing 8K | CO | |
SEC Filing 10Q-3 | CO | |
Slide show Q3 | CO | |
3rd quarter results | CO | |
SEC Filing 10Q-2 | CO | |
Slide show half-year results | CO | |
1st-half-year results | CO | |
SEC Filing 8K | CO | |
Dividends | CO | |
Shareholders meeting voting results | CO | |
Dividends | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Official Publications